|
With the pandemic gripping the world in a virulent second wave, pharma and healthcare providers look to further strengthen their digital technology initiatives. This, according to Indium Software, will enable companies to sustain their operations in a competitive environment.
In pharma, with multiple systems of execution across manufacturing, quality and supply chain, there is a reinforced need for platforms that bring aggregate information, to collaborate and facilitate timely decisions.
Particularly in R&D, large value-creation or idea generation opportunities require the need to digitalize the entire value-chain. Large cross functional processes like new product lifecycle management, annual product quality reviews etc. involve substantial scope for digitalization to make it more efficient, error-free and automated.
Digital transformation is now focused on improving operational efficiency, integrated approach toward patient care, automated administrative and clinical processes, enhanced innovation and delivering better patient outcomes, said Arunkumar Sampath, associate vice president, Indium Software.
The prevailing pandemic situation has laid a challenge for large healthcare companies to step-up their game around digital transformation. Factors like agility, accuracy, efficiency, and quick turnaround time are considered as key focus areas in delivering software applications to cover the length and breadth of the services rendered by the healthcare organizations, he added.
Analytics enable better decision making and improve transparency across multiple teams who depend on critical information access to execute their processes. Building digital platforms that cater to the need of bringing process, people and data together help improve speed of execution and engage people in a free flow ideation, foster better problem solving and innovation. Creating an entire new software is expensive, time consuming and delays the go-to-market need of the drug. Hence we see the need for pharma and healthcare adopt new age applications and tools to be competitive, Sampath told Pharmabiz.
Any digital transformation initiative should focus data, process, people, and business objectives to deliver excellence as well as services. Therefore, both pharma and healthcare should also assess the viability of how low-code which is a modern approach to software development to accelerates digital transformation. Here low code automates every step of the application lifecycle and allows swift delivery software solutions, he said.
The current and future scenario will sustain low-code application to bring flexible opportunities to the business users. The future of development is going to be low-code primarily because of ease of development at any complexity level, said Sampath.
|